Table 4.
Clinicopathologic features of previously published epithelioid hemangioendotheliomas of the head and neck
| Reference (#) (Year) | #’s of Cases | Age/ Gender | Size (cm) | Site | Treatment | Follow-up |
|---|---|---|---|---|---|---|
| 2, 1997 | 5 | 30–65 years/4M-1F | 0.4–4.0 | ST, Cheek and Neck | SE | NED 42–60 months |
| 13, 1986 | 1 | NA/ M | NA | Gingiva | SE | NED 36 months |
| 14, 1986 | 1 | 4–67 years/7M-5F | 1.7–2.5 | Neck ST, Gingiva | WLE and SE | LN mets-2 cases, Rec.-1 case |
| 15, 1987 | 1 | 25 years/F | 1.0 | Palate | SE | NED 21 months |
| 16, 1987 | 1 | 4 years/M | NA | Gingiva | SE | NA |
| 17, 1991 | 2 | 36–45 years /1M-1F | 0.2–1.5 | Tongue, Gingiva | SE | Rec. 1 case |
| 18, 2007 | 9 | 6–53y years/8M-1F | 0.5–7.0 | Tongue, FOM, Oral Cavity | WLE | Rec.-3 Cases |
| NED 6–96 months | ||||||
| 19, 1995 | 1 | 7 years/F | 1.5 | Gingiva | WLE | NED 48 months |
| 20, 1996 | 1 | 46 years/M | 1.0 | ST, Cheek | SE | NED 36 months |
| 21, 1998 | 1 | 44 years/F | 3.7 | Thyroid | Subtotal Thyroidectomy | NED 24 months |
| 22, 1999 | 1 | 19 years/M | 1.5 | Larynx | SE | NED 36 months |
| 23, 2000 | 1 | 48 years/F | 2.0 | Parotid | NA | NA |
| 24, 2001 | 1 | 18 years/F | NA | Buccal Mucosa | SE | Rec. 9 months |
| Rec. WLE | NED 24 months | |||||
| 25, 2003 | 1 | 23 years/M | NA | Nasal Cavity | WLE | NED 12 months |
| 26, 2003 | 1 | 81 years/M | 2.0 | Parotid | Total Parotidectomy | NED 7 months |
| 27, 2004 | 1 | 28 years/M | NA | Parotid | Parotidectomy and LN dissection | NA |
| 28, 2005 | 1 | 25 years/M | NA | Nasal cavity | WLE | NA |
| 29, 2005 | 1 | 28 years/F | 0.6 | Gingiva | SE | NED 8 months |
| 30, 2006 | 1 | 34 years/F | 2.5 | ST, Neck | SE | NED 84 months |
Abbreviations: AWD: Alive With Disease; Cm: Centimeters; F: Female; LN: Lymph Node; M: Male; Mets: Metastases; NA: Not Available; NED: No Evidence of Disease; Rec: Recurrence; SE: Simple excision; ST: Soft Tissue; WLE: Wide Local Excision; #: Number; FOM: Floor of mouth